Taysha: Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
DALLAS, June 26, 2024 (GLOBE NEWSWIRE) - Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing... Read More The post Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants appeared first on citybiz.
Read full article »
Taysha is a Texas-based biotechnology company that researches and develops gene therapies for the treatment of monogenic central nervous system disorders.
Read more